Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568710 · ClinicalTrials.gov registry record
Blood Flow and Pain Crises in People With Sickle Cell Disease
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 94
- Enrollment target
NCT01568710: Completed study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT01568710 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 94 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01568710 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
Study Summary
Background: \- Many people with sickle cell disease have repeated episodes of severe pain that lasts for days, requiring hospital care. These episodes, called pain crises, may be caused by changes in blood flow. Researchers want to study blood flow in people with sickle cell disease who are having a pain crisis and compare it with their blood flow after the pain crisis has resolved. They also want to compare these measurements against blood flow in healthy people who do not have sickle cell disease. Objectives: \- To study whether changes in blood flow cause pain crises in people with sickle cell disease. Eligibility: * Individuals at least 18 years of age who have sickle cell disease and are being treated for a pain crisis. * Individuals at least 18 years of age who have sickle cell disease and are not experiencing a pain crisis. * Healthy volunteers matched by age and gender with the participants who have sickle cell disease. Design: * Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected. * Participants having a sickle cell pain crisis will have two visits, one during the crisis and one about 4 weeks after the crisis has resolved. * Participants not having a sickle cell pain crisis will have one or two study visits. Blood samples will be collected during at least one of these visits. * Healthy volunteers will have one or two study visits. Blood samples will be collected during at least one of these visits. * During each visit for all participants, cameras and blood flow monitoring equipment will be used to measure blood flow in the forearm. sickle cell disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2012-03-21 |
| Est. Completion | 2018-10-05 |
What the finished NCT01568710 record still lists
NCT01568710 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01568710 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01568710 about?
NCT01568710 is a clinical study titled "Blood Flow and Pain Crises in People With Sickle Cell Disease". Background: \- Many people with sickle cell disease have repeated episodes of severe pain that lasts for days, requiring hospital care. These episodes, called pain crises, may be caused by changes in blood flow. Researchers want to study blood flow in people with sickle cell disease who are having ...
What is the current status of trial NCT01568710?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2012-03-21. Estimated completion is 2018-10-05.
Who is sponsoring clinical trial NCT01568710?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI